- Home
- TARS vs FSM Comparison
TARS vs FSM Comparison
Compare TARS & FSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARS | FSM |
|---|---|---|
| Founded | 2016 | 1990 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.9B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | TARS | FSM |
|---|---|---|
| Price | $71.64 | $10.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $76.56 | $11.00 |
| AVG Volume (30 Days) | 709.0K | ★ 7.0M |
| Earning Date | 02-24-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 809.52 |
| EPS | N/A | ★ 0.74 |
| Revenue | $366,100,000.00 | ★ $1,256,829,000.00 |
| Revenue This Year | $147.34 | $0.28 |
| Revenue Next Year | $53.50 | $11.27 |
| P/E Ratio | ★ N/A | $13.78 |
| Revenue Growth | ★ 182.44 | 68.17 |
| 52 Week Low | $38.51 | $4.13 |
| 52 Week High | $85.25 | $10.82 |
Technical Indicators
Market Signals| Indicator | TARS | FSM |
|---|---|---|
| Relative Strength Index (RSI) | 26.51 | 58.37 |
| Support Level | $76.91 | $9.70 |
| Resistance Level | $76.22 | $10.82 |
| Average True Range (ATR) | 3.15 | 0.46 |
| MACD | -1.09 | -0.01 |
| Stochastic Oscillator | 0.12 | 71.57 |
Price Performance
Historical ComparisonAbout TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About FSM Fortuna Silver Mines Inc (Canada)
Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'Ivoire, Mexico, and Peru. The company's segment consists of Mansfield, Sanu, Sango, Cuzcatlan, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d'Ivoire location.